Efficacy of bispectral index monitoring as an adjunct to propofol deep sedation for ERCP: a randomized controlled trial

Background and study aims: We sought to determine whether bispectral index (BIS) monitoring is a useful adjunct to the administration of propofol titrated to deep sedation, as measured by reductions of doses of propofol administered during endoscopic retrograde cholangiopancreatography (ERCP).

Patients and methods: 90 consecutive patients undergoing ERCP were randomized to receive propofol titrated to deep sedation, with the BIS value either visible (BIS group, n = 46) or invisible (control group, n = 44) to the anesthesiologist. In the BIS group, the anesthesiologist was instructed to use the BIS value as the primary end point for titration of sedation, and to target BIS values between 40 and 60. For the control group, the anesthesiologist was instructed to titrate propofol according to routine practice in the unit using the modified Observer’s Assessment of Alertness/Sedation (MOAA/S) Scale (MOAA/S score 0).

Results: The mean (SD) propofol doses (mg/min per kg weight) were 0.139 (0.02) and 0.193 (0.02) for the BIS and control groups, respectively (P < 0.001). Mean (SD) BIS values throughout the procedure were 61.68 (7.5) and 56.93 (4.77) for the BIS and control groups, respectively (P = 0.001). During the maintenance phase of sedation (MOAA/S score 0), the mean (SD) BIS values were 53.73 (8.67) and 45.65 (4.39) for the BIS and control groups, respectively (P < 0.001).

Conclusions: Our data suggest that BIS monitoring led to a reduction in the mean propofol dose when the BIS value was used as the primary target for sedation in ERCP procedures.

References

• 1 Soehle M, Ellerkmann R K, Grube M. et al . Comparison between bispectral index and patient state index as measures of the electroencephalographic effects of sevoflurane.  Anesthesiology. 2008;  109 799-805
• 2 Al-Sammak Z, Al-Falaki M M, Gamal H M. Predictor of sedation during endoscopic retrograde cholangiopancreatography – bispectral index vs clinical assessment.  Middle East J Anesthesiol. 2005;  18 141-148
• 3 Chen S C, Rex D K. An initial investigation of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy.  Am J Gastroenterol. 2004;  99 1081-1086
• 4 Drake L M, Chen S C, Rex D K. Efficacy of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy: a randomized controlled trial.  Am J Gastroenterol. 2006;  101 2003-2007
• 5 Qadeer M A, Vargo J J, Patel S. et al . Bispectral index monitoring of conscious sedation with the combination of meperidine and midazolam during endoscopy.  Clin Gastroenterol Hepatol. 2008;  6 102-108
• 6 Cohen L B. Patient monitoring during gastrointestinal endoscopy: why, when, and how?.  Gastrointest Endosc Clin N Am. 2008;  18 651-663
• 7 Bower A L, Ripepi A, Dilger J. et al . Bispectral index monitoring of sedation during endoscopy.  Gastrointest Endosc. 2000;  52 192-196
• 8 Krugliak P, Ziff B, Rusabrov Y. et al . Propofol versus midazolam for conscious sedation guided by processed EEG during endoscopic retrograde cholangiopancreatography: a prospective, randomized, double-blind study.  Endoscopy. 2000;  32 677-682
• 9 Wehrmann T, Grotkamp J, Stergiou N. et al . Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: a randomized, controlled trial.  Gastrointest Endosc. 2002;  56 817-824
• 10 Riphaus A, Stergiou N, Wehrmann T. Sedation with propofol for routine ERCP in high-risk octogenarians: a randomized, controlled study.  Am J Gastroenterol. 2005;  100 1957-1963
• 11 Seifert H, Schmitt T H, Gultekin T. et al . Sedation with propofol plus midazolam versus propofol alone for interventional endoscopic procedures: a prospective, randomized study.  Aliment Pharmacol Ther. 2000;  14 1207-1214
• 12 Vargo J J, Zuccaro Jr. G, Dumot J A. et al . Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial.  Gastroenterology. 2002;  123 8-16
• 13 Wehrmann T, Kokabpick S, Lembcke B. et al . Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study.  Gastrointest Endosc. 1999;  49 677-683
• 14 Wysowski D K, Pollock M L. Reports of death with use of propofol (Diprivan) for nonprocedural (long-term) sedation and literature review.  Anesthesiology. 2006;  105 1047-1051
• 15 Keats A S. The ASA classification of physical status – a recapitulation.  Anesthesiology. 1978;  49 233-236
• 16 Rex D K. Review article: moderate sedation for endoscopy: sedation regimens for non-anaesthesiologists.  Aliment Pharmacol Ther. 2006;  24 163-171
• 17 Nelson D B, Barkun A N, Block K P. et al . Propofol use during gastrointestinal endoscopy.  Gastrointest Endosc. 2001;  53 876-879
• 18 Aldrete J A, Kroulik D. A postanesthetic recovery score.  Anesth Analg. 1970;  49 924-934
• 19 Paspatis G A, Manolaraki M M, Vardas E. et al . Deep sedation for endoscopic retrograde cholangiopancreatography: intravenous propofol alone versus intravenous propofol with oral midazolam premedication.  Endoscopy. 2008;  40 308-313
• 20 Zuccaro Jr G. Sedation and analgesia for GI endoscopy.  Gastrointest Endosc. 2006;  63 95-96
• 21 Lichtenstein D R, Jagannath S, Baron T H. et al . Sedation and anesthesia in GI endoscopy.  Gastrointest Endosc. 2008;  68 815-826
• 22 Imagawa A, Fujiki S, Kawahara Y. et al . Satisfaction with bispectral index monitoring of propofol-mediated sedation during endoscopic submucosal dissection: a prospective, randomized study.  Endoscopy. 2008;  40 905-909
• 23 Patel S, Vargo J J, Khandwala F. et al . Deep sedation occurs frequently during elective endoscopy with meperidine and midazolam.  Am J Gastroenterol. 2005;  100 2689-2695
• 24 Liu S S. Effects of bispectral index monitoring on ambulatory anesthesia: a meta-analysis of randomized controlled trials and a cost analysis.  Anesthesiology. 2004;  101 311-315
• 25 Gan T J, Glass P S, Windsor A. et al . Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. BIS Utility Study Group.  Anesthesiology. 1997;  87 808-815
• 26 Myles P S, Leslie K, McNeil J. et al . Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial.  Lancet. 2004;  363 1757-1763
• 27 Avidan M S, Zhang L, Burnside B A. et al . Anesthesia awareness and the bispectral index.  N Engl J Med. 2008;  358 1097-1108
• 28 Yarchi D, Cohen A, Umansky T. et al . Assessment of end-tidal carbon dioxide during pediatric and adult sedation for endoscopic procedures.  Gastrointest Endosc. 2009;  69 877-882
• 29 Cohen L B, Delegge M H, Aisenberg J. et al . AGA Institute review of endoscopic sedation.  Gastroenterology. 2007;  133 675-701
• 30 Aisenberg J, Cohen L B, Piorkowski Jr. J D. Propofol use under the direction of trained gastroenterologists: an analysis of the medicolegal implications.  Am J Gastroenterol. 2007;  102 707-713
• 31 Heuss L T, Froehlich F, Beglinger C. Changing patterns of sedation and monitoring practice during endoscopy: results of a nationwide survey in Switzerland.  Endoscopy. 2005;  37 161-166
• 32 Rex D K, Heuss L T, Walker J A. et al . Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy.  Gastroenterology. 2005;  129 1384-1391
• 33 Vargo J J. Propofol may be safely administered by trained nonanesthesiologists. Pro: Propofol demystified: it is time to change the sedation paradigm.  Am J Gastroenterol. 2004;  99 1207-1208
• 34 Riphaus A, Wehrmann T, Weber B. et al . S3-Guideline: Sedation for gastrointestinal endoscopy 2008. AWMF-Register-No. 021/014.  Endoscopy. 2009;  41 787-815
• 35 Kulling D, Orlandi M, Inauen W. Propofol sedation during endoscopic procedures: how much staff and monitoring are necessary?.  Gastrointest Endosc. 2007;  66 443-449